Q3312831 (Q3312831): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed an Item: Edited by the infer coords bot - inferring coordinates from location) |
||||||||||
| Property / coordinate location | |||||||||||
49°13'20.17"N, 8°21'59.72"E
| |||||||||||
| Property / coordinate location: 49°13'20.17"N, 8°21'59.72"E / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 20:03, 24 October 2021
Project Q3312831 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3312831 in Germany |
Statements
516,561.12 Euro
0 references
1,067,495.6 Euro
0 references
48.39 percent
0 references
17 March 2020
0 references
31 March 2022
0 references
HWI pharma services GmbH
0 references
49°13'20.17"N, 8°21'59.72"E
0 references
76761
0 references
Mit der innovativen Screening- und Technologie-Plattform lassen sich parenterale (sterile) Arzneimittel mit schwerlöslichen chemischen und biologischen Wirkstoffen mittels Nanotechnologie schneller, effizienter und kostengünstiger entwickeln und herstellen. (German)
0 references
Germersheim
0 references
Identifiers
DE_TEMPORARY_15618
0 references